GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (STU:HG6) » Definitions » Other Cash Payments from Operating Activities

Mayne Pharma Group (STU:HG6) Other Cash Payments from Operating Activities : €0.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Mayne Pharma Group Other Cash Payments from Operating Activities?

Mayne Pharma Group's Other Cash Payments from Operating Activities for the six months ended in Jun. 2024 was €0.0 Mil.

Mayne Pharma Group's Other Cash Payments from Operating Activities for the trailing twelve months (TTM) ended in Jun. 2024 was €0.0 Mil.


Mayne Pharma Group Other Cash Payments from Operating Activities Historical Data

The historical data trend for Mayne Pharma Group's Other Cash Payments from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Other Cash Payments from Operating Activities Chart

Mayne Pharma Group Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Cash Payments from Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mayne Pharma Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Cash Payments from Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.32 -5.12 4.98 - -

Mayne Pharma Group Other Cash Payments from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Other Cash Payments from Operating Activities represents cash flow paid from other operating activities in the direct cash flow method.

GuruFocus lists following items in "Cash Payments" section for non-financial companies:
Payments to Suppliers for Goods and Services
Payments on Behalf of Employees
Other Cash Payments from Operating Activities

Other Cash Payments from Operating Activities for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mayne Pharma Group Other Cash Payments from Operating Activities Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Other Cash Payments from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Mayne Pharma Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (STU:HG6) » Definitions » Other Cash Payments from Operating Activities
Traded in Other Exchanges
Address
1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.

Mayne Pharma Group Headlines

No Headlines